Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Acquisitions (2024)

Nuvation Bio (NUVB) has disclosed Acquisitions for 1 consecutive years, with -$1000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Acquisitions changed N/A to -$1000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was -$1000.0, a 0.0% change, with the full-year FY2024 number at $19.9 million, changed N/A from a year prior.
  • Acquisitions was -$1000.0 for Q4 2024 at Nuvation Bio.
  • In the past five years, Acquisitions ranged from a high of -$1000.0 in Q4 2024 to a low of -$1000.0 in Q4 2024.